Comparing Fatigue in MS and Parkinsonβs Disease | #multiplesclerosis #parkinsons
Sedative Effects on Cognition in Different Age Groups #CNS #Cognition #Cogstate #benzodiazepines
Trends in the #Alzheimer Drug Development Pipeline #clinicaldevelopment #alzheimersresearch
Sleep Clinical Trials: 2 Key Concepts #neuroscience #cognition #clinicalresearch
2 Key Aspects in Rare Neurodevelopmental Disorder Trials | Phelan McDermid Syndrome
How Decentralized Clinical Trials Support Patients & Caregivers
Why Clinical Trial Teams Choose Digital Endpoints #clinicalresearch #neuroscience #clinicaltrials
The situation with placebo groups in rare disease clinical trials #neuroscience #clinicalresearch
Correcting Errors & Improving Clinical Trial Outcomes with Central Scoring
Rare Disease Research Multi-Indication Trials Explained
Targeting symptoms that matter to patients in rare disease trials π§¬
Approaching Clinical Trials in Ultra Rare Diseases π§¬
Test Selection in #RareDisease Clinical Trials π§ π
What is PRECLINICAL Alzheimer's Disease? π§
Remote cognitive testing feasibility and acceptability data | clinical trials
A Paradox in Digital Memory Assessment: Increased Sensitivity With Reduced Difficulty
Differentiate Cognitive CHANGE from Cognitive IMPAIRMENT π§ π
Revision & Improvements to the Cogstate Brief Battery & it's Sensitivity to Cognitive Impairment π§
Global Central Rating Case Study | Rare Neurodevelopment Clinical Trials π§¬
Clinical Outcome Assessments in REMOTE Psychiatric Clinical Trials | Central Rating | MADRS & HAM-D
Common Rater Errors in Clinical Depression Scales | MADRS & HAM-D | Halo Effect
Central Rating with Clinically Depressed Populations | Psychiatric Trials | Mood Disorders
Double Blinding is CRUCIAL in Clinical Trials | Psychiatric Trials | Central Rating
Increasing Diversity in Raters & Participants in Clinical Trials π
CAR T-Cell Therapy in Children & Young Adults #clinicaltrials #oncology #pediatrics
Neuroscientist Unpacks Jet Lag's Effects on the Brain π§ π₯±
Demonstrating Cognitive Safety of NMDA Modulator Antidepressant Medications - Esketamine Case Study
How to REDUCE COSTS of Alzheimer's Drug Development π§ π
X
About
At Cogstate, we believe that brain health is profoundly important to quality of life and should be easier to measure. That is why we so passionately apply our expertise, access to data and flexible technology to radically simplify the assessment of cognition and other outcome measures to improve clinical research and clinical care around the world. Watch videos from our team to learn more about our efforts.
Tags